MIRCETTE COMPONENT ETHINYL ESTRADIOL

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

38 API Suppliers, 14 USDMF, 10 CEP/COS, 4 JDMF, 1 EU WC, 14 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

25 Drugs in Development

25 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

729 FDF Dossiers, 418 FDA Orange Book, 107 Europe, 88 Canada, 56 South Africa, 60 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL-28 - 0.02MG;1MG, TABLET;ORAL-21 - 0.03MG;1.5MG, TABLET;ORAL-28 - 0.03MG;0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-21 - 0.03MG;1.5MG, TABLET;ORAL-21 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.035MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG, TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.035MG;0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-21 - 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A, CAPSULE;ORAL - 0.02MG;1MG, TABLET, CHEWABLE, TABLET;ORAL - 0.01MG,0.01MG,N/A;1MG,N/A,N/A, TABLET;ORAL - 0.02MG;0.1MG, RING;VAGINAL - 0.013MG/24HR;0.15MG/24HR, TABLET;ORAL - 0.0025MG;0.5MG, TABLET;ORAL - 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.035MG/24HR;0.15MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, RING;VAGINAL - 0.015MG/24HR;0.12MG/24HR, TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.035MG;0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 3MG;0.02MG, TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A, TABLET, CHEWABLE;ORAL - 0.025MG;0.8MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 5 SPI Pharma, 6 DKSH, 7 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 25 BASF, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 1 Finar, 8 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 38 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 7 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 12 Sigachi Industries, 5 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

74 Fillers, Diluents & Binders, 55 Coating Systems & Additives, 31 Controlled & Modified Release, 31 Disintegrants & Superdisintegrants, 26 Granulation, 26 Thickeners and Stabilizers, 25 Direct Compression, 20 Lubricants & Glidants, 16 Taste Masking, 16 Solubilizers, 13 Co-Processed Excipients, 12 Topical, 10 Film Formers & Plasticizers, 8 Parenteral, 7 Rheology Modifiers, 7 Chewable & Orodispersible Aids, 7 API Stability Enhancers, 6 Emulsifying Agents, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 152 News #PharmaBuzz

GLOBAL SALES INFORMATION

31 US Medicaid Prescriptions, 101 Regulatory FDF Prices, 22 Annual Reports

MARKET PLACE

17 APIs, 3 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

30 US Patents, 1 US Exclusivities, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 3 JP, 3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

01

SYMBIOTEC PHARMALAB PRIVATE LIMITED...

India

CPhI WW Frankfurt

Booth #12.1D45

Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.

Contact Supplier

India

Virtual Booth

Digital Content

Ethinylestradiol, Micronised

Certificate Number : R0-CEP 2020-029 - Rev 00

Status : Valid

Issue Date : 2021-10-06

Type : Chemical

Substance Number : 140

Corporate PDF

02

ASPEN OSS B.V. Oss NL

Netherlands

TIDES USA

Booth #27, Level 2

Aspen API. More than just an API™

Contact Supplier

Netherlands

Virtual Booth

Digital Content

Ethinylestradiol

Certificate Number : R2-CEP 1995-022 - Rev 05

Status : Valid

Issue Date : 2014-01-30

Type : Chemical

Substance Number : 140

03

BAYER AG Leverkusen DE

Germany

BioProcess International Europe

Not Confirmed

04

GEDEON RICHTER PLC Budapest HU

Hungary

BioProcess International Europe

Not Confirmed

05

Industriale Chimica S.R.L. Saronno ...

Italy

BioProcess International Europe

Not Confirmed

06

Jenapharm GmbH & Co KG Jena DE

Germany

BioProcess International Europe

Not Confirmed

07

LUPIN LIMITED Mumbai IN

India

BioProcess International Europe

Not Confirmed

08

QINHUANGDAO ZIZHU PHARMACEUTICAL CO...

China

BioProcess International Europe

Not Confirmed

09

ZHEJIANG XIANJU PHARMACEUTICAL CO.,...

China

BioProcess International Europe

Not Confirmed

10

ZHEJIANG XIANJU PHARMACEUTICAL CO.,...

China

BioProcess International Europe

Not Confirmed

Looking for 57-63-6 / Ethinyl Estradiol API manufacturers, exporters & distributors?

PharmaCompass offers a list of Ethinyl Estradiol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ethinyl Estradiol manufacturer or Ethinyl Estradiol supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ethinyl Estradiol manufacturer or Ethinyl Estradiol supplier.

PharmaCompass also assists you with knowing the Ethinyl Estradiol API Price utilized in the formulation of products. Ethinyl Estradiol API Price is not always fixed or binding as the Ethinyl Estradiol Price is obtained through a variety of data sources. The Ethinyl Estradiol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Ethinyl Estradiol

Synonyms

Ethynylestradiol, 57-63-6, Ethinylestradiol, Ethynyl estradiol, Ethinyloestradiol, 17-ethinylestradiol

Cas Number

57-63-6

Unique Ingredient Identifier (UNII)

423D2T571U

About Ethinyl Estradiol

A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.

MIRCETTE COMPONENT ETHINYL ESTRADIOL Manufacturers

A MIRCETTE COMPONENT ETHINYL ESTRADIOL manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MIRCETTE COMPONENT ETHINYL ESTRADIOL, including repackagers and relabelers. The FDA regulates MIRCETTE COMPONENT ETHINYL ESTRADIOL manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MIRCETTE COMPONENT ETHINYL ESTRADIOL API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of MIRCETTE COMPONENT ETHINYL ESTRADIOL manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

MIRCETTE COMPONENT ETHINYL ESTRADIOL Suppliers

A MIRCETTE COMPONENT ETHINYL ESTRADIOL supplier is an individual or a company that provides MIRCETTE COMPONENT ETHINYL ESTRADIOL active pharmaceutical ingredient (API) or MIRCETTE COMPONENT ETHINYL ESTRADIOL finished formulations upon request. The MIRCETTE COMPONENT ETHINYL ESTRADIOL suppliers may include MIRCETTE COMPONENT ETHINYL ESTRADIOL API manufacturers, exporters, distributors and traders.

click here to find a list of MIRCETTE COMPONENT ETHINYL ESTRADIOL suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

MIRCETTE COMPONENT ETHINYL ESTRADIOL CEP

A MIRCETTE COMPONENT ETHINYL ESTRADIOL CEP of the European Pharmacopoeia monograph is often referred to as a MIRCETTE COMPONENT ETHINYL ESTRADIOL Certificate of Suitability (COS). The purpose of a MIRCETTE COMPONENT ETHINYL ESTRADIOL CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of MIRCETTE COMPONENT ETHINYL ESTRADIOL EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of MIRCETTE COMPONENT ETHINYL ESTRADIOL to their clients by showing that a MIRCETTE COMPONENT ETHINYL ESTRADIOL CEP has been issued for it. The manufacturer submits a MIRCETTE COMPONENT ETHINYL ESTRADIOL CEP (COS) as part of the market authorization procedure, and it takes on the role of a MIRCETTE COMPONENT ETHINYL ESTRADIOL CEP holder for the record. Additionally, the data presented in the MIRCETTE COMPONENT ETHINYL ESTRADIOL CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the MIRCETTE COMPONENT ETHINYL ESTRADIOL DMF.

A MIRCETTE COMPONENT ETHINYL ESTRADIOL CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. MIRCETTE COMPONENT ETHINYL ESTRADIOL CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of MIRCETTE COMPONENT ETHINYL ESTRADIOL suppliers with CEP (COS) on PharmaCompass.

MIRCETTE COMPONENT ETHINYL ESTRADIOL Manufacturers | Traders | Suppliers

We have 9 companies offering MIRCETTE COMPONENT ETHINYL ESTRADIOL

Get in contact with the supplier of your choice:

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.

MIRCETTE COMPONENT ETHINYL ESTRADIOL

MIRCETTE COMPONENT ETHINYL ESTRADIOL

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

38 API Suppliers

14 USDMF

10 CEP/COS

4 JDMF

1 EU WC

14 NDC API

15 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

25 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

729 FDF Dossiers

418 FDA Orange Book

107 Europe

88 Canada

56 South Africa

60 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL-28 - 0.02MG;1MG

TABLET;ORAL-21 - 0.03MG;1.5MG

TABLET;ORAL-28 - 0.03MG;0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-21 - 0.03MG;1.5MG

TABLET;ORAL-21 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.035MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.035MG;0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-21 - 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A

CAPSULE;ORAL - 0.02MG;1MG

TABLET, CHEWABLE, TABLET;ORAL - 0.01MG,0.01MG,N/A;1MG,N/A,N/A

TABLET;ORAL - 0.02MG;0.1MG

RING;VAGINAL - 0.013MG/24HR;0.15MG/24HR

TABLET;ORAL - 0.0025MG;0.5MG

TABLET;ORAL - 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.035MG/24HR;0.15MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RING;VAGINAL - 0.015MG/24HR;0.12MG/24HR

TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.035MG;0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 3MG;0.02MG

TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A

TABLET, CHEWABLE;ORAL - 0.025MG;0.8MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc

5 SPI Pharma

6 DKSH

7 Faran Shimi Pharmaceutical

4 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 ACG Worldwide

5 Actylis

1 Aeon Procare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

25 BASF

2 Clariant

11 Corel Pharma Chem

7 DFE Pharma

1 Doshion Polyscience

1 Finar

8 Gangwal Chemicals

7 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

38 Kerry

TABLET;ORAL-28 - 0.03MG;0.3MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-21 - 0.02MG;1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-28 - 0.035MG;1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-28 - 0.035MG;0.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-21 - 0.15MG;0.03MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.02MG;1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.005MG;1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.035MG/24HR;0.15MG/24HR Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.035MG;0.4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.02MG;1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons